VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 16, 2008) - Med BioGene Inc. (TSX VENTURE:MBI), a life science company focused on the development and commercialization of genomic-based diagnostic and screening tests for cancer and cardiovascular disease, is pleased to announce that it has expanded its lymphoma collaboration with Duke University Medical Center to include Northwestern University, Indiana University and the University of Hong Kong. Discussions are currently underway with other leading universities who are expected to join the Working Group.
